Patent directory · USPTO A61K / A61P
Patents matching “inhibitor”
2,878 pharma patents match "inhibitor" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 2,878 pharmaceutical patents matching "inhibitor" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 12329748
Anhydrous compositions of mTOR inhibitors and methods of use
granted -
US 12329829
Kit for radiolabelling with 68GA comprising a metal inhibitor
granted -
US 12331058
SHP2 and CDK4/6 dual-target inhibitory compound and pharmaceutical composition containing the same
granted -
US 12331026
Sulfonamido derivatives as cyclin-dependent kinase 2 inhibitors
granted -
US 12331036
Heterocyclic RIP1 kinase inhibitors
granted -
US 12325703
Fused ring compound as FGFR and VEGFR dual inhibitor
granted -
US 12318386
Combination of XPO1 inhibitors and second agents for the treatment of prostate cancer
granted -
US 12319703
Macrocyclic fused pyrazoles as Mcl-1 inhibitors
granted -
US 12310944
Selective butyrylcholinesterase inhibitor or pharmaceutically acceptable salt thereof, preparation method and use thereof
granted -
US 12312339
Polo like kinase 4 inhibitors
granted -
US 12312348
RET inhibitors, pharmaceutical compositions and uses thereof
granted -
US 12304912
Fused bicyclic RAF inhibitors and methods for use thereof
granted -
US 12295941
Viral inhibitors, the synthesis thereof, and intermediates thereto
granted -
US 12295940
Viral inhibitors, the synthesis thereof, and intermediates thereto
granted -
US 12297186
Benzylamide derivatives as inhibitors of transforming growth factor-beta receptor I/ALK5
granted -
US 12297209
Benzodiazepine derivatives as RSV inhibitors
granted -
US 12297202
RIP1K inhibitors
granted -
US 12297203
Pyrrolopyrimidine ITK inhibitors
granted -
US 12291502
Topoisomerase II-alpha inhibitors and methods of treating cancer using the same
granted -
US 12286405
Scalable synthesis of dual-target inhibitor of cannabinoid-1 receptor and inducible nitric oxide synthase
granted -
US 12286431
Crystalline forms of a KRas G12C inhibitor
granted -
US 12286406
Inhibitors of receptor interacting protein kinase I for the treatment of disease
granted -
US 12280113
Ras inhibitors
granted -
US 12281113
Crystalline forms of a KRas G12C inhibitor
granted